PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3010% below fair value
$16.94+1.18 (+7.49%)
Close on Nov 18, 2026Market cap $2.35BP/E –Yield 6.85%
Perrigo net income
Net income is the profit left for shareholders after every expense, interest and tax.
Perrigo's net income for the twelve months ending Jun 27, 2026 was -$1.73B. For fiscal 2025 it was -$1.43B. The highest annual figure on record is $441.90M in fiscal 2013.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.43B | – |
| FY2024 | Dec 31, 2024 | -$171.80M | – |
| FY2023 | Dec 31, 2023 | -$12.70M | – |
| FY2022 | Dec 31, 2022 | -$140.60M | – |
| FY2021 | Dec 31, 2021 | -$68.90M | – |
| FY2020 | Dec 31, 2020 | -$162.60M | -211.3% |
| FY2019 | Dec 31, 2019 | $146.10M | +11.5% |
| FY2018 | Dec 31, 2018 | $131.00M | +9.5% |
| FY2017 | Dec 31, 2017 | $119.60M | -12.1% |
| FY2015 | Jun 27, 2015 | $136.10M | -41.5% |
| FY2014 | Jun 28, 2014 | $232.80M | -47.3% |
| FY2013 | Jun 29, 2013 | $441.90M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 27, 2026 | $74.50M | – |
| Q1 FY2026CQ1 2026 | Mar 28, 2026 | -$398.60M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$1.42B | – |
| Q3 FY2025CQ3 2025 | Sep 27, 2025 | $7.50M | – |
| Q2 FY2025CQ2 2025 | Jun 28, 2025 | -$8.40M | – |
| Q1 FY2025CQ1 2025 | Mar 29, 2025 | -$6.40M | -420.0% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$44.50M | – |
| Q3 FY2024CQ3 2024 | Sep 28, 2024 | -$21.00M | -247.9% |
| Q2 FY2024CQ2 2024 | Jun 29, 2024 | -$108.40M | -1390.5% |
| Q1 FY2024CQ1 2024 | Mar 30, 2024 | $2.00M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$32.30M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $14.20M | – |
| Q2 FY2023CQ2 2023 | Jul 1, 2023 | $8.40M | – |
| Q1 FY2023CQ1 2023 | Apr 1, 2023 | -$3.00M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$23.70M | -346.9% |
| Q3 FY2022CQ3 2022 | Oct 1, 2022 | -$49.40M | – |
| Q2 FY2022CQ2 2022 | Jul 2, 2022 | -$65.10M | – |
| Q1 FY2022CQ1 2022 | Apr 2, 2022 | -$2.40M | -106.3% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $9.60M | – |
| Q3 FY2021CQ3 2021 | Oct 2, 2021 | -$58.90M | – |
| Q2 FY2021CQ2 2021 | Jul 3, 2021 | -$57.70M | -195.2% |
| Q1 FY2021CQ1 2021 | Apr 3, 2021 | $38.10M | -64.2% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$175.00M | – |
| Q3 FY2020CQ3 2020 | Sep 26, 2020 | -$154.60M | -267.7% |
| Q2 FY2020CQ2 2020 | Jun 27, 2020 | $60.60M | +573.3% |
| Q1 FY2020CQ1 2020 | Mar 28, 2020 | $106.40M | +66.5% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$19.00M | -123.3% |
| Q3 FY2019CQ3 2019 | Sep 28, 2019 | $92.20M | – |
| Q2 FY2019CQ2 2019 | Jun 29, 2019 | $9.00M | -75.1% |
| Q1 FY2019CQ1 2019 | Mar 30, 2019 | $63.90M | -20.9% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $81.50M | +11.5% |
| Q3 FY2018CQ3 2018 | Sep 29, 2018 | -$67.50M | -251.7% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $36.20M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $80.80M | +12.8% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $73.10M | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $44.50M | – |
| Q2 FY2017CQ2 2017 | Jul 1, 2017 | -$69.60M | – |
| Q1 FY2017CQ1 2017 | Apr 1, 2017 | $71.60M | – |
| Q4 FY2015CQ2 2015 | Jun 27, 2015 | -$22.20M | – |
| Q3 FY2015CQ1 2015 | Mar 28, 2015 | -$22.20M | – |
See a number that looks wrong?